chr11-6390700-CCTGGTGCTGGCG-C

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_000543.5(SMPD1):​c.107_118delTGCTGGCGCTGG​(p.Val36_Leu39del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0753 in 1,546,630 control chromosomes in the GnomAD database, including 4,521 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V36V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.063 ( 331 hom., cov: 0)
Exomes 𝑓: 0.076 ( 4190 hom. )

Consequence

SMPD1
NM_000543.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 1.67

Publications

7 publications found
Variant links:
Genes affected
SMPD1 (HGNC:11120): (sphingomyelin phosphodiesterase 1) The protein encoded by this gene is a lysosomal acid sphingomyelinase that converts sphingomyelin to ceramide. The encoded protein also has phospholipase C activity. Defects in this gene are a cause of Niemann-Pick disease type A (NPA) and Niemann-Pick disease type B (NPB). Multiple transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2010]
SMPD1 Gene-Disease associations (from GenCC):
  • acid sphingomyelinase deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Niemann-Pick disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Niemann-Pick disease type A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • Niemann-Pick disease type B
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000543.5
BP6
Variant 11-6390700-CCTGGTGCTGGCG-C is Benign according to our data. Variant chr11-6390700-CCTGGTGCTGGCG-C is described in ClinVar as Benign. ClinVar VariationId is 193113.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0821 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMPD1NM_000543.5 linkc.107_118delTGCTGGCGCTGG p.Val36_Leu39del disruptive_inframe_deletion Exon 1 of 6 ENST00000342245.9 NP_000534.3 P17405-1Q59EN6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMPD1ENST00000342245.9 linkc.107_118delTGCTGGCGCTGG p.Val36_Leu39del disruptive_inframe_deletion Exon 1 of 6 1 NM_000543.5 ENSP00000340409.4 P17405-1

Frequencies

GnomAD3 genomes
AF:
0.0631
AC:
8772
AN:
139088
Hom.:
332
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0185
Gnomad AMI
AF:
0.0443
Gnomad AMR
AF:
0.0493
Gnomad ASJ
AF:
0.0877
Gnomad EAS
AF:
0.0680
Gnomad SAS
AF:
0.0780
Gnomad FIN
AF:
0.106
Gnomad MID
AF:
0.0971
Gnomad NFE
AF:
0.0840
Gnomad OTH
AF:
0.0717
GnomAD2 exomes
AF:
0.0703
AC:
16351
AN:
232506
AF XY:
0.0722
show subpopulations
Gnomad AFR exome
AF:
0.0149
Gnomad AMR exome
AF:
0.0367
Gnomad ASJ exome
AF:
0.0920
Gnomad EAS exome
AF:
0.0691
Gnomad FIN exome
AF:
0.0981
Gnomad NFE exome
AF:
0.0820
Gnomad OTH exome
AF:
0.0732
GnomAD4 exome
AF:
0.0765
AC:
107636
AN:
1407438
Hom.:
4190
AF XY:
0.0764
AC XY:
53525
AN XY:
700294
show subpopulations
African (AFR)
AF:
0.0144
AC:
476
AN:
33120
American (AMR)
AF:
0.0389
AC:
1675
AN:
43040
Ashkenazi Jewish (ASJ)
AF:
0.0934
AC:
2363
AN:
25308
East Asian (EAS)
AF:
0.0632
AC:
2265
AN:
35850
South Asian (SAS)
AF:
0.0678
AC:
5590
AN:
82494
European-Finnish (FIN)
AF:
0.0960
AC:
4777
AN:
49768
Middle Eastern (MID)
AF:
0.0827
AC:
464
AN:
5608
European-Non Finnish (NFE)
AF:
0.0799
AC:
85799
AN:
1074212
Other (OTH)
AF:
0.0728
AC:
4227
AN:
58038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
6084
12168
18252
24336
30420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3134
6268
9402
12536
15670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0630
AC:
8773
AN:
139192
Hom.:
331
Cov.:
0
AF XY:
0.0630
AC XY:
4263
AN XY:
67702
show subpopulations
African (AFR)
AF:
0.0185
AC:
699
AN:
37864
American (AMR)
AF:
0.0492
AC:
704
AN:
14320
Ashkenazi Jewish (ASJ)
AF:
0.0877
AC:
295
AN:
3362
East Asian (EAS)
AF:
0.0683
AC:
328
AN:
4802
South Asian (SAS)
AF:
0.0776
AC:
315
AN:
4060
European-Finnish (FIN)
AF:
0.106
AC:
945
AN:
8948
Middle Eastern (MID)
AF:
0.102
AC:
26
AN:
256
European-Non Finnish (NFE)
AF:
0.0840
AC:
5290
AN:
62962
Other (OTH)
AF:
0.0730
AC:
140
AN:
1918
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
386
772
1159
1545
1931
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0430
Hom.:
38

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 20, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SMPD1 c.107_118del12 (p.Val36_Leu39del) results in an in-frame deletion that is predicted to remove four amino acids from the encoded protein. The variant allele was found at a frequency of 0.07 in 232506 control chromosomes in the gnomAD database, including 641 homozygotes. The observed variant frequency is approximately 31.45 fold of the estimated maximal expected allele frequency for a pathogenic variant in SMPD1 causing Niemann-Pick Disease Type A phenotype (0.0022), strongly suggesting that the variant is benign. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 22, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 24, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 02, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Niemann-Pick disease, type A Benign:1
May 06, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.7
Mutation Taster
=198/2
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs550365194; hg19: chr11-6411930; COSMIC: COSV54966432; COSMIC: COSV54966432; API